Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytes

Masakazu Fukuda1, Takeshi Yamamoto1, Shigehiko Nishimura1

  • 1Department of Medicine and Clinical Science, Division of Cardiology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.

Abstract

Insights

Calmodulin (CaM) dysfunction in CPVT causes RyR2 channel issues. Enhancing CaM binding affinity to RyR2 corrects CPVT-linked channel disorders, offering a potential therapeutic strategy.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Ion Channel Biophysics

Background:

  • Calmodulin (CaM) is crucial for regulating ryanodine receptor type 2 (RyR2) channel gating.
  • Catecholaminergic polymorphic ventricular tachycardia (CPVT) is linked to RyR2 channel dysfunction.

Purpose of the Study:

  • Investigate the pathogenic role of CaM in CPVT-associated RyR2 channel disorders.
  • Evaluate the potential of correcting CPVT-linked channel dysfunction using a knock-in (KI) mouse model with an RyR2 mutation (R2474S).

Main Methods:

  • Utilized a knock-in (KI) mouse model with the CPVT-associated RyR2 R2474S mutation.
  • Recorded transmembrane potentials in isolated ventricular myocytes.
  • Assessed CaM binding affinity to RyR2 using fluorescently labeled CaM and a modified GSH-CaM with higher binding affinity.
  • Measured Ca(2+) spark frequency and spontaneous Ca(2+) transients.

Main Results:

  • CPVT-mutant RyR2 channels exhibited decreased CaM binding affinity, particularly in the presence of cAMP.
  • The modified GSH-CaM restored normal CaM binding to RyR2 in KI cells.
  • KI cells showed increased incidence of delayed afterdepolarizations (DADs) and triggered activity (TA), which were reduced by GSH-CaM.
  • GSH-CaM significantly decreased Ca(2+) spark frequency and spontaneous Ca(2+) transients in KI cells.

Conclusions:

  • CPVT-associated RyR2 mutations impair CaM binding, leading to channel dysfunction.
  • Enhancing CaM binding affinity to RyR2, using agents like GSH-CaM, can correct CPVT-related channel abnormalities.
  • This suggests a potential therapeutic approach for CPVT by modulating CaM-RyR2 interactions.

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.0K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
2.4K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.8K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.5K